Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Prevention of NAFLD and CVD Through Lifestyle Intervention [NA]
A clinical trial run by Pontificia Universidad Catolica de Chile is recruiting to assess whether lifestyle interventions can prevent non-alc…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic Patients [NA]
A completed clinical trial comparing strategies for screening, referral, and management of diabetic patients with non-alcoholic fatty liver …
-
CLINICAL_TRIALS research · 2024-11-13Clinical Trial Update: Integrated Multi-omics Data for Personalized Treatment of Obesity-associated Fatty Liver Disease
This clinical trial aims to use integrated multi-omics data to personalize treatment for obesity-associated non-alcoholic fatty liver diseas…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Soluble Fibre Supplementation in NAFLD [Phase 2]
A Phase 2 clinical trial is evaluating soluble fibre supplementation for non-alcoholic fatty liver disease and related conditions and is cur…
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: Effect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy
Clinical trial status update showing NOT_YET_RECRUITING for the study on SGLT2 inhibitors' effect on non-alcoholic fatty liver disease in pa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: Intermittent Fasting Versus Diet to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic Fatty Liver Patients [NA]
A Cairo University clinical trial compares intermittent fasting versus a diet in patients with non-alcoholic fatty liver disease to assess e…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Effects of Time-restricted Hypocaloric Diet in Patients with NAFLD [NA]
A completed clinical trial evaluated the effects of time-restricted hypocaloric dieting in individuals with non-alcoholic fatty liver diseas…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Effects of VLCKD in Metabolic Syndrome [NA]
A clinical trial is evaluating the effects of a very low calorie ketogenic diet (VLCKD) on metabolic syndrome and related conditions, includ…
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Intermittent Fasting, Mediterranean Diet and NAFLD [NA]
A ClinicalTrials.gov study from Italy is evaluating intermittent fasting and a Mediterranean diet in people with non-alcoholic fatty liver d…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Genetic-specific Effects of Fructose on Liver Lipogenesis [NA]
A completed clinical trial from the University of North Carolina examined how genetic factors influence fructose-induced liver lipogenesis i…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study
Clinical trial NCT05712603, The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study, has completed according to ClinicalTrials.gov.
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy
This clinical trial in adults with type 2 diabetes evaluates the risk of non-alcoholic fatty liver disease in clinical practice and assesses…
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement Study
A clinical trial update confirms the Movement Study evaluating smart watch insights to prevent exacerbations and support rehabilitation is c…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: N-acetyl Cysteine and Patients with Non-alcoholic Fatty Liver Disease [Phase 3]
Phase 3 trial update noting completion of a study evaluating N-acetylcysteine in patients with non-alcoholic fatty liver disease (simple ste…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Liver and Metabolic Effects of Insulin Pump Therapy in Diabetics Type 2 with Non-alcoholic Hepatic Steatosis [NA]
Completed study assessing liver and metabolic effects of insulin pump therapy in adults with type 2 diabetes and non-alcoholic fatty liver d…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study
A Singapore-based cohort study called Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease (RESET) is investigati…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Combined Active Treatment in Type 2 Diabetes with NASH [Phase 4]
A Phase 4 clinical trial evaluating a combined active treatment approach for type 2 diabetes mellitus with non-alcoholic steatohepatitis (NA…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Pharmacoeconomic Evaluation of the Cost/effectiveness Ratio of Physical Exercise on Non-alcoholic Fatty Liver Disease
This completed clinical trial evaluated the cost-effectiveness of physical exercise for non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: Fructose and Liver Diseases in Youth: Help Them FLY [NA]
A University of Alberta clinical trial is recruiting to study the effects of fructose on liver disease in youth with Non-alcoholic Fatty Liv…
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Effectiveness of Nutrition Education Program and Omega-3 Supplementation Among Non-alcoholic Fatty Liver Disease Patients [NA]
A clinical trial evaluating a nutrition education program combined with omega-3 supplementation in non-alcoholic fatty liver disease is not …
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet. [NA]
A clinical trial is evaluating the effect of a ketogenic diet on gut permeability in patients with obesity and non-alcoholic fatty liver dis…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases [NA]
A clinical study funded by Jinling Hospital in China is evaluating hyperbaric oxygen therapy for metabolic dysfunction-associated steatotic …
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers [Phase 1]
A Phase 1 trial completed to evaluate the effect of food on the pharmacokinetics of ASC41 in healthy volunteers, with study context includin…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: DDI Study of ASC41 in HV and the PK, Safety and Tolerability in Subjects With NAFLD. [Phase 1]
Phase 1 trial update for ASC41, including a drug-drug interaction study in healthy volunteers and pharmacokinetics, safety, and tolerability…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Treating Pediatric NAFLD with Nutrition [NA]
A completed clinical trial from the University of California, San Diego evaluates nutrition-based interventions for pediatric Non-Alcoholic …